Literature DB >> 35501176

Screening for Colorectal Cancer.

Samir Gupta1.   

Abstract

Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. Screening reduces CRC incidence and mortality. 2021 US Preventive Service Task Force (USPSTF) guidelines and available evidence support routine screening from ages 45 to 75, and individualized consideration of screening ages 76 to 85. USPSTF guidelines recommend annual guaiac fecal occult blood testing, annual fecal immunochemical testing (FIT), annual to every 3-year multitarget stool DNA-FIT, every 5-year sigmoidoscopy, every 10-year sigmoidoscopy with annual FIT, every 5-year computed tomographic colonography, and every 10-year colonoscopy as options for screening. The "best test is the one that gets done." Published by Elsevier Inc.

Entities:  

Keywords:  Colorectal cancer; Early detection; Incidence; Mortality; Prevention; Screening

Mesh:

Year:  2022        PMID: 35501176      PMCID: PMC9167799          DOI: 10.1016/j.hoc.2022.02.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   2.861


  43 in total

1.  Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.

Authors:  Sujha Subramanian; Mayur M Amonkar; Timothy L Hunt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

2.  The Effects of Direct Oral Anticoagulants, Warfarin, Aspirin and Thienopyridine on the Performance of Immunochemical, Faecal, Occult Blood Tests.

Authors:  Ryota Niikura; Atsuo Yamada; Mitsuhiro Fujishiro; Kiyohito Tanaka; Koji Matsuda; Yutaka Saito; Kazuo Ohtsuka; Ichiro Oda; Chikatoshi Katada; Masayuki Kato; Mitsuhiro Kida; Kiyonori Kobayashi; Shu Hoteya; Takahiro Horimatsu; Shinya Kodashima; Takahisa Matsuda; Manabu Muto; Hironori Yamamoto; Shomei Ryozawa; Ryuichi Iwakiri; Hiromu Kutsumi; Hiroaki Miyata; Mototsugu Kato; Ken Haruma; Kazuma Fujimoto; Naomi Uemura; Michio Kaminishi; Tomohiro Shinozaki; Hisao Tajiri; Kazuhiko Koike
Journal:  Digestion       Date:  2018-11-08       Impact factor: 3.216

Review 3.  Colorectal cancer.

Authors:  Evelien Dekker; Pieter J Tanis; Jasper L A Vleugels; Pashtoon M Kasi; Michael B Wallace
Journal:  Lancet       Date:  2019-10-19       Impact factor: 79.321

4.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

Authors:  Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jørn Schneede; Kjell Magne Tveit; Geir Hoff
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

Review 5.  Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.

Authors:  Perry J Pickhardt; Cesare Hassan; Steve Halligan; Riccardo Marmo
Journal:  Radiology       Date:  2011-03-17       Impact factor: 11.105

6.  Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.

Authors:  O Kronborg; O D Jørgensen; C Fenger; M Rasmussen
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

7.  Antithrombotic drug does not affect the positive predictive value of an immunochemical fecal occult blood test.

Authors:  Yosuke Tsuji; Toshiaki Gunji; Hajime Sato; Akiko Ono; Takafumi Ito; Ken Ohata; Nobutake Yamamichi; Mitsuhiro Fujishiro; Nobuyuki Matsuhashi; Kazuhiko Koike
Journal:  Dig Endosc       Date:  2013-12-10       Impact factor: 7.559

8.  Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review.

Authors:  Reinier G S Meester; Marinika M A G C van Herk; Iris Lansdorp-Vogelaar; Uri Ladabaum
Journal:  Gastroenterology       Date:  2020-03-18       Impact factor: 22.682

9.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jennifer S Lin; Leslie A Perdue; Nora B Henrikson; Sarah I Bean; Paula R Blasi
Journal:  JAMA       Date:  2021-05-18       Impact factor: 56.272

10.  Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening.

Authors:  Takashi Ibuka; Seiji Adachi; Yohei Horibe; Tomohiko Ohno; Masatoshi Mabuchi; Yusuke Suzuki; Osamu Yamauchi; Eri Takada; Midori Iwama; Koshiro Saito; Masamichi Arao; Koji Takai; Hiroshi Araki; Masahito Shimizu
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

View more
  1 in total

1.  The Spectrum of Co-Diagnoses in Patients with Colorectal Cancer: A Retrospective Cohort Study of 17,824 Outpatients in Germany.

Authors:  Sven H Loosen; David Schöler; Simon Labuhn; Alexander Mertens; Markus S Jördens; Mark Luedde; Karel Kostev; Tom Luedde; Christoph Roderburg
Journal:  Cancers (Basel)       Date:  2022-08-06       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.